ALG5
Dolichyl-phosphate beta-glucosyltransferase
Also known as: ALG5_HUMAN, bA421P11.2
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9Y673
- Gene
- ALG5
- Ensembl
- ENSG00000120697
- Chromosome
- 13
- Canonical length
- 324 aa
- Protein class
- Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins
- Subcellular location
- Cytosol
OverviewNCBI Gene
This gene encodes a member of the glycosyltransferase 2 family. The encoded protein participates in glucosylation of the oligomannose core in N-linked glycosylation of proteins. The addition of glucose residues to the oligomannose core is necessary to ensure substrate recognition, and therefore, effectual transfer of the oligomannose core to the nascent glycoproteins. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Nov 2008]
Canonical amino-acid sequenceUniProt
324 residues, UniProt reviewed canonical sequence.
>Q9Y673|ALG5
1 MAPLLLQLAV LGAALAAAAL VLISIVAFTT ATKMPALHRH EEEKFFLNAK GQKETLPSIW
61 DSPTKQLSVV VPSYNEEKRL PVMMDEALSY LEKRQKRDPA FTYEVIVVDD GSKDQTSKVA
121 FKYCQKYGSD KVRVITLVKN RGKGGAIRMG IFSSRGEKIL MADADGATKF PDVEKLEKGL
181 NDLQPWPNQM AIACGSRAHL EKESIAQRSY FRTLLMYGFH FLVWFLCVKG IRDTQCGFKL
241 FTREAASRTF SSLHVERWAF DVELLYIAQF FKIPIAEIAV NWTEIEGSKL VPFWSWLQMG
301 KDLLFIRLRY LTGAWRLEQT RKMNLocalizationUniProt · AlphaFold · HPA
Whether an antibody against ALG5 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Other membrane
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.26
- Highest tissue expression
- 80 nTPM
Expression across tissuesHPA
Tissue
- pancreas: 80 nTPM
- epididymis: 74 nTPM
- liver: 58 nTPM
- thyroid gland: 51 nTPM
- salivary gland: 49 nTPM
- rectum: 44 nTPM
Single-cell type
- plasma cells: 238 nCPM
- epididymal principal cells: 165 nCPM
- pancreatic acinar cells: 161 nCPM
- gastric chief cells: 153 nCPM
- gastric progenitor cells: 135 nCPM
- parietal cells: 134 nCPM
Immune cell
- plasmacytoid DC: 109 nTPM
- total PBMC: 69 nTPM
- T-reg: 66 nTPM
- intermediate monocyte: 62 nTPM
- basophil: 59 nTPM
- myeloid DC: 57 nTPM
Brain region
- choroid plexus: 13 nTPM
- white matter: 12 nTPM
- medulla oblongata: 11 nTPM
- spinal cord: 10 nTPM
- hypothalamus: 10 nTPM
- cerebellum: 9.4 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about ALG5.
Disease | AllUniProt
Conditions ALG5 is implicated in, by any mechanism.
- Polycystic kidney disease 7 (PKD7) MIM:620056
Disease | GeneticClinVar
9 pathogenic / likely-pathogenic of 77 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Polycystic kidney disease 7
- Gastric cancer
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.45
- gnomAD pLI
- 0.46
- gnomAD missense Z
- 1.01
- DepMap mean gene effect
- -0.3
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 6% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- determination of left/right symmetry
- dolichol-linked oligosaccharide biosynthetic process
- protein N-linked glycosylation
- protein N-linked glycosylation via asparagine
Molecular functions
- dolichyl-phosphate beta-glucosyltransferase activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Glycosyltransferase 2-like
- Nucleotide-diphospho-sugar transferases
- Glycosyl transferase family 2
- Dolichyl-phosphate beta-glucosyltransferase
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads ALG5 as an antibody target. Whether an autoantibody or antibody against ALG5 could matter depends on whether native ALG5 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
ALG5 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label ALG5 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...